705 Anti-tumor activity of CB-668, a potent, selective and orally bioavailable small-molecule inhibitor of the immuno-suppressive enzyme Interleukin 4 (IL-4)-Induced Gene 1 (IL4I1)

Bibliographic Details
Main Authors: Andrew Mackinnon, Jason Chen, Natalija Sotirovska, Susanne Steggerda, Francesco Parlati, Tony Huang, Weiqun Li, Winter Zhang, Yong Ma, Deepthi Bhupathi
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer